Doula Support for Postpartum Care
(PeliCaN Trial)
Trial Summary
What is the purpose of this trial?
This is a randomized controlled trial of a dyad-centered, doula support and healthcare coordination model of care in a large urban neonatal intensive care unit (NICU), which serves a high-risk, low-income, majority Black population. In addition to doula support and coordination of care in the NICU, there will be a warm handoff to a community doula to continue the support once infants leave the Hospital of the University of Pennsylvania (HUP) NICU.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Doula Support for Postpartum Care?
Research shows that doula support during the perinatal period (the time shortly before and after birth) is linked to better outcomes for mothers and babies, such as fewer early births, more mothers starting to breastfeed, and higher satisfaction with the birth experience. Doulas also help reduce health differences among different racial groups, making them a valuable support for new mothers.12345
Is doula support safe for postpartum care?
Research shows that doula support is generally safe and beneficial for mothers and infants, improving outcomes like reduced medical interventions and increased breastfeeding success. Doulas provide emotional and physical support, which can lead to a more positive birth experience and better postpartum recovery.14678
How is Doula Support different from other postpartum treatments?
Research Team
Heather Burris, MD MPH
Principal Investigator
University of Pennsylvania
Eligibility Criteria
This trial is for new mothers experiencing postpartum depression, anxiety, or PTSD after giving birth prematurely. Participants should be from a high-risk, low-income background and will receive care in the NICU of the Hospital of the University of Pennsylvania.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive doula support and healthcare coordination in the NICU, with a warm handoff to a community doula for continued support post-discharge
Follow-up
Participants are monitored for PTSD and depression symptoms, and attendance with a primary care provider is assessed
Treatment Details
Interventions
- Doula Support (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pennsylvania
Lead Sponsor
Dr. Joan Lau
University of Pennsylvania
Chief Executive Officer since 2020
PhD in Neuroscience from the University of Cincinnati College of Medicine, MBA from the Wharton School of Business, BS in Bioengineering from the University of Pennsylvania
Dr. Robert Iannone
University of Pennsylvania
Chief Medical Officer since 2019
MD from Yale University, MSCE from the University of Pennsylvania